FDA inspection

Azurity Pharmaceuticals, Inc.: FDA inspection ending Apr 29, 2004

FDA inspection 327426 · No Action Indicated (NAI) · Wilmington, MA

Key facts

Inspection ID 327426
Firm Azurity Pharmaceuticals, Inc.
FEI number 3003395329
Address 841 Woburn St
City Wilmington
State MA
ZIP 01887-3414
Fiscal year 2004
Inspection end date Apr 29, 2004
Classification No Action Indicated (NAI)
Project area Compliance: Med Devices
Product type Devices

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections